- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 264.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 271.25M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 263.41M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 267.84M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.06B |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $182.74M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $852.69M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $5.94B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.94B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $564.61M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $452.11M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.21B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $11.29B |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $9.97B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.48B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $14.79B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.47B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $10.28B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.19B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.7B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $15.37B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $14.88B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $19.68B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $20.39B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $28.85B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $29.67B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.49 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.49 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $376.09M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $394.35M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $525.65M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $355.37M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$394.12M |
| Net Income | Q1 2026 · Mar 31, 2025 | $65.61M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$21.42M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $705.81M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.41B |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.03B |